LIAN BRIAN (President & CEO) sold 8.5% of their position (233.41K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $7.69M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, par value $0.00001 per share
Shares
+78.40K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
+224.08K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
−132.45K
Price / share
$32.29
Trade value
$4.28M
% of position
Common Stock, par value $0.00001 per share
Shares
−53.28K
Price / share
$33.38
Trade value
$1.78M
% of position
Common Stock, par value $0.00001 per share
Shares
−41.28K
Price / share
$34.22
Trade value
$1.41M
% of position
Common Stock, par value $0.00001 per share
Shares
−6.40K
Price / share
$35.07
Trade value
$224.42K
% of position
Net shares
+69.07K
Net value
-$7.69M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 1/2/2026 | A · Award | +78.40K | — | — | 3.2% | 2.43M | 2.51M |
| Common Stock, par value $0.00001 per share Direct | 1/2/2026 | A · Award | +224.08K | — | — | 8.9% | 2.51M | 2.73M |
| Common Stock, par value $0.00001 per share Direct | 1/5/2026 | S · Sale | −132.45K | $32.29 | $4.28M | 4.8% | 2.73M | 2.60M |
| Common Stock, par value $0.00001 per share Direct | 1/5/2026 | S · Sale | −53.28K | $33.38 | $1.78M | 2.0% | 2.60M | 2.55M |
| Common Stock, par value $0.00001 per share Direct | 1/5/2026 | S · Sale | −41.28K | $34.22 | $1.41M | 1.6% | 2.55M | 2.51M |
| Common Stock, par value $0.00001 per share Direct | 1/5/2026 | S · Sale | −6.40K | $35.07 | $224.42K | 0.3% | 2.51M | 2.50M |
| Total | +69.07K | -$7.69M | ||||||
Stock Option (Right to Buy)
Common Stock
176.30K shares
Shares
+176.30K
Strike price
35.42
Held after
176.30K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock176.30K shares | 1/2/2026 | A · Award | +176.30K | 35.42 | — | 176.30K |